HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sawada, S. Articles by Feigenbaum, H. Search for Related Content PubMed PubMed Citation Articles by Sawada, S. Articles by Feigenbaum, H.

CLINICAL RESEARCH: MYOCARDIAL VIABILITY AND PROGNOSIS

Incremental value of myocardial viability for prediction of Long-Term prognosis in surgically revascularized patients with left ventricular dysfunction

Stephen Sawada, MD, FACC^*,*, Ashutosh Bapat, MD^*, Dev Vaz, MD^*, Juan Weksler, MD^*, Naomi Fineberg, PhD^*, Adam Greene, MD, FACC^*, Irmina Gradus-Pizlo, MD, FACC^* and Harvey Feigenbaum, MD, FACC^*

^* Department of Medicine of Indiana University School of Medicine, Indianapolis, Indiana, USA
Krannert Institute of Cardiology, Indianapolis, Indiana, USA

^* Reprint requests and correspondence: Dr. Stephen Sawada, 1801 North Senate Boulevard, M.P.C. II, Suite D4082, Indianapolis, Indiana 46202, USA.
ssawada{at}iupui.edu

OBJECTIVES: We assessed the incremental long-term prognostic value of myocardial viability in surgically revascularized (CABG) patients with left ventricular (LV) dysfunction.

BACKGROUND: Clinical factors, medical therapy, the degree of LV dysfunction, and stress-induced ischemia may affect the relative prognostic value of myocardial viability.

METHODS: Patients with coronary disease and ventricular dysfunction (mean ejection fraction 33% by echocardiography, 25% by angiography) were studied with dobutamine echocardiography. Follow-up (mean –4.9 years) was obtained in 95 patients (85% triple-vessel disease) who underwent CABG.

RESULTS: The use of angiotensin-converting enzyme inhibitors, advanced heart failure, rest, low- and peak-dose wall motion scores were univariate predictors of cardiac death. The extent of contractile reserve and ischemia were not predictive. Low-dose score was the strongest multivariate predictor of death (p < 0.001, hazard ratio 6.7). A biphasic response predicted better survival (p = 0.045, hazard ratio 0.5). Five-year survival was better in those with extensive (low-dose score <2.00) versus intermediate (score 2.00 to 2.49) amounts of viable myocardium (p = 0.019). Patients with the least viability (score 2.5) had the worst outcome (p = 0.0001 vs. those with low-dose score <2.00; p = 0.05 vs. those with score 2.00 to 2.49). In stepwise multivariate analysis, low-dose score added incremental prognostic value (p = 0.024) to clinical information and rest score.

CONCLUSIONS: Low-dose score, representing the extent of viable myocardium, has incremental prognostic value as a predictor of long-term outcome in CABG patients with LV dysfunction.

Abbreviations and Acronyms   ACEI = angiotensin-converting enzyme inhibitor   CABG = coronary artery bypass grafting   CAD = coronary artery disease   CHF = congestive heart failure   DobE = dobutamine echocardiography   EF = ejection fraction   LV = left ventricle/ventricular

This article has been cited by other articles:

				R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC) Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437. [Abstract] [Full Text] [PDF]

				V Rizzello, D Poldermans, A F L Schinkel, E Biagini, E Boersma, A Elhendy, F B Sozzi, A Maat, F Crea, J R T C Roelandt, et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation Heart, February 1, 2006; 92(2): 239 - 244. [Abstract] [Full Text] [PDF]

				J. J. DeRose Jr, I. K. Toumpoulis, S. K. Balaram, J. P. Ioannidis, S. Belsley, R. C. Ashton Jr, D. G. Swistel, and C. E. Anagnostopoulos Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 314 - 321. [Abstract] [Full Text] [PDF]